Monte Rosa Therapeutics (GLUE)
US Market

Monte Rosa Therapeutics (GLUE) Balance Sheet


Monte Rosa Therapeutics Balance Sheet

Monte Rosa Therapeutics's total assets for Q3 2023 were $252.10M, a decrease of -9.52% from the previous quarter. GLUE total liabilities were $67.58M for the fiscal quarter, a 4.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 342.39M$ 366.33M$ 49.38M$ 11.09M
Total Liabilities
$ 70.98M$ 18.81M$ 98.11M$ 23.24M
Total Equity Gross Minority
$ 271.45M$ 347.51M$ -48.73M$ -12.15M
Total Capitalization
$ 315.29M$ 347.51M$ -48.73M$ -12.15M
Preferred Stock Equity
Capital Lease Obligations
Currency in USD

Monte Rosa Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis